Mark Ragosa - 01 Apr 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

SEC form
4
Accepted by SEC
03 Apr 2025, 17:04:18 UTC
Prior SEC filing
24 Mar 2025
Next SEC filing
09 Apr 2025
Source filing
View source filing
Filing notes and source

Key filing fact

Mark Ragosa filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 03 Apr 2025.

Key facts

  • This page summarizes Mark Ragosa's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
  • 9 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2025, 17:04.

Change

  • Previous filing in this sequence was filed on 24 Mar 2025.
  • Current net transaction value: -$35,202.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+1,750
Change %
+7.5%
Price
Shares after
25,132
Date
01 Apr 2025
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+1,592
Change %
+6.3%
Price
Shares after
26,724
Date
01 Apr 2025
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Tax liability

Transaction value
-$18,439
Shares
-847
Change %
-3.2%
Price
$21.77
Shares after
25,877
Date
01 Apr 2025
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Tax liability

Transaction value
-$16,763
Shares
-770
Change %
-3%
Price
$21.77
Shares after
25,107
Date
01 Apr 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KNSA transaction Derivative

Share Option

Award

Transaction value
$0
Shares
+29,480
Change %
Price
$0.000000
Shares after
29,480
Date
01 Apr 2025
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
29,480
Exercise price
$21.77
Footnotes
F2
KNSA transaction Derivative

Restricted Share Unit

Award

Transaction value
$0
Shares
+7,382
Change %
Price
$0.000000
Shares after
7,382
Date
01 Apr 2025
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
7,382
Exercise price
Footnotes
F1, F3
KNSA transaction Derivative

Performance Share Unit

Award

Transaction value
$0
Shares
+14,765
Change %
Price
$0.000000
Shares after
14,765
Date
01 Apr 2025
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
14,765
Exercise price
Footnotes
F4, F5
KNSA transaction Derivative

Restricted Share Unit

Options Exercise

Transaction value
$0
Shares
-1,750
Change %
-33%
Price
$0.000000
Shares after
3,500
Date
01 Apr 2025
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
1,750
Exercise price
Footnotes
F1, F6
KNSA transaction Derivative

Restricted Share Unit

Options Exercise

Transaction value
$0
Shares
-1,592
Change %
-25%
Price
$0.000000
Shares after
4,773
Date
01 Apr 2025
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
1,592
Exercise price
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Footnote F2

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April1, 2025.

Footnote F3

The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025.

Footnote F4

Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee

Footnote F5

Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2028, unless such date falls on a non-business date, in which case the next business date shall apply.

Footnote F6

The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.

Footnote F7

The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .